Primary |
Psychotic Disorder |
27.3% |
Overdose |
22.7% |
Hallucinations, Mixed |
18.2% |
Drug Use For Unknown Indication |
9.1% |
Asperger's Disorder |
4.5% |
Bipolar Disorder |
4.5% |
Cardiogenic Shock |
4.5% |
Muscle Rigidity |
4.5% |
Paranoia |
4.5% |
|
Death |
12.5% |
Catatonia |
6.3% |
Hypotension |
6.3% |
Muscle Twitching |
6.3% |
Neuroleptic Malignant Syndrome |
6.3% |
Oedema Peripheral |
6.3% |
Off Label Use |
6.3% |
Pyrexia |
6.3% |
Shock |
6.3% |
Speech Disorder |
6.3% |
Stupor |
6.3% |
Tachycardia |
6.3% |
Tremor |
6.3% |
Urinary Retention |
6.3% |
Vomiting |
6.3% |
|
Secondary |
Product Used For Unknown Indication |
30.6% |
Drug Use For Unknown Indication |
20.5% |
Bipolar Disorder |
14.3% |
Psychotic Disorder |
5.7% |
Overdose |
4.2% |
Mental Disorder |
3.2% |
Abnormal Behaviour |
2.7% |
Agitation |
2.7% |
Urinary Tract Infection |
2.5% |
Cardiogenic Shock |
2.3% |
Ill-defined Disorder |
2.1% |
Suicide Attempt |
2.1% |
Anxiety |
1.7% |
Major Depression |
1.5% |
Sleep Disorder |
1.1% |
Aggression |
0.6% |
Hiv Infection |
0.6% |
Traumatic Brain Injury |
0.6% |
Brief Psychotic Disorder With Marked Stressors |
0.4% |
Delirium |
0.4% |
|
Neuroleptic Malignant Syndrome |
15.3% |
Disseminated Intravascular Coagulation |
8.3% |
Dystonia |
8.3% |
Overdose |
8.3% |
Status Epilepticus |
8.3% |
Toxic Epidermal Necrolysis |
5.6% |
Toxicity To Various Agents |
5.6% |
Weight Increased |
5.6% |
Cardiogenic Shock |
4.2% |
Alanine Aminotransferase Increased |
2.8% |
Blood Pressure Decreased |
2.8% |
Completed Suicide |
2.8% |
Heart Rate Increased |
2.8% |
Hepatotoxicity |
2.8% |
Hypoglycaemia |
2.8% |
Muscle Rigidity |
2.8% |
Respiratory Disorder |
2.8% |
Sedation |
2.8% |
Sepsis |
2.8% |
Somnolence |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
24.8% |
Drug Use For Unknown Indication |
12.8% |
Schizophrenia |
9.4% |
Bipolar Disorder |
7.1% |
Depression |
6.7% |
Schizophrenia, Paranoid Type |
6.2% |
Psychotic Disorder |
5.3% |
Anxiety |
4.4% |
Asthma |
2.7% |
Pain |
2.4% |
Diabetes Mellitus |
2.3% |
Metastases To Bone |
2.1% |
Arthritis |
2.0% |
Breast Cancer |
2.0% |
Hypertension |
2.0% |
Smoking Cessation Therapy |
1.8% |
Dissociative Identity Disorder |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Intervertebral Disc Degeneration |
1.5% |
Insomnia |
1.4% |
|
Weight Increased |
10.3% |
Type 2 Diabetes Mellitus |
9.2% |
Psychotic Disorder |
8.0% |
Treatment Noncompliance |
8.0% |
Vomiting |
6.9% |
Memory Impairment |
5.7% |
Overdose |
5.7% |
Tricuspid Valve Incompetence |
4.6% |
White Blood Cell Count Decreased |
4.6% |
Aggression |
3.4% |
Drug Dose Omission |
3.4% |
Drug Level Fluctuating |
3.4% |
Dysphagia |
3.4% |
Pneumonia |
3.4% |
Restlessness |
3.4% |
Schizophrenia |
3.4% |
Suicide Attempt |
3.4% |
Syncope |
3.4% |
Tremor |
3.4% |
Agranulocytosis |
2.3% |
|
Interacting |
Delusion |
33.3% |
Psychotic Disorder |
33.3% |
Schizophrenia |
33.3% |
|
Abnormal Behaviour |
40.0% |
Joint Dislocation |
40.0% |
Gun Shot Wound |
20.0% |
|